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A B S T R A C T
A 58-year-old man was admitted for non-ST-elevation myocardial infarction. A medicated stent was
used for severe coronary artery stenosis. However, consciousness level progressively deteriorated after
angioplasty. Computed tomography showed no brain lesion but laboratory tests showed hyponatremia
(serum sodium: 113 meq./l) and urine analysis showed syndrome of inappropriate antidiuretic hormone
secretion (SIADH). SIADH was ﬁrst suspected to be drug-induced by enalapril. However, hyponatremia
persisted even after withdrawal of enalapril and required oral sodium intake. Hormone assays indicated
secondary adrenal insufﬁciency, which was caused by adrenocorticotropic hormone (ACTH) deﬁciency.
Furthermore, in addition to ACTH deﬁciency, adult growth hormone deﬁciency was diagnosed following
tests. Treatment with hydrocortisone relieved hyponatremia and re-institution of enalapril did not
reduce serum sodium concentration. The ﬁnal diagnosis was hyponatremia caused by hypopituitarism.
<Learning objective: Secondary adrenal insufﬁciency with subsequent hypopituitarism should be
suspected in cases with sudden-onset and prolonged hyponatremia in acute illness. Furthermore, the
management of hypopituitarism should include assessment of growth hormone release to exclude
growth hormone deﬁciency.>
 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Various disease states are associated with hyponatremia [1,2].
In acute coronary syndrome (ACS), one study reported the
presence of hyponatremia on admission in 20 (10.5%) of 235
patients with myocardial infarction, and demonstrated that
hyponatremia in the early phase of ACS was a predictor of
negative clinical outcome [3].
ACS results in marked activation of the renin–angiotensin
system and increased catecholamine production. These factors
promote renal vasoconstriction leading to diminished glomerular
ﬁltration rate and subsequent delivery of tubular ﬂuid to the
diluting segment of the nephron, further contributing to a* Corresponding author at: Department of Cardiovascular Medicine, Graduate
School of Medical Sciences, Kumamoto University, 1-1-1, Honjo, Chuo-ku,
Kumamoto 860-8556, Japan. Tel.: +81 96 373 5175; fax: +81 96 362 3256.
E-mail address: arimay@kumamoto-u.ac.jp (Y. Arima).
http://dx.doi.org/10.1016/j.jccase.2014.08.002
1878-5409/ 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rightreduction in renal water excretion. Consequently, patients with
ACS are predisposed to hyponatremia, especially in the presence of
marked neurohormonal activation [4]. We describe a patient who
presented with non-ST-elevation myocardial infarction (NSTEMI),
developed disturbances of consciousness following angioplasty,
and was found to have hyponatremia associated with adrenal
insufﬁciency and hypopituitarism.
Case report
A 58-year-old Japanese man with no past medical history
visited our hospital due to exacerbating chest pain, which
appeared 6 months earlier. He had visited a general practitioner
1 week before, and the electrocardiogram (ECG) and chest X-ray
taken at that visit showed no signiﬁcant ﬁndings. The coronary risk
factors included dyslipidemia and smoking, but he was free of
other risk factors including hypertension, diabetes mellitus, and
familial history. His height, weight, and body mass index weres reserved.
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growth in childhood. He did not take any medications.
On admission, the ECG showed inverted T wave in V1–4 (Fig. 1),
and blood tests showed leukocyte count of 7000 mm3, serum
sodium of 137 meq./l, potassium of 4.4 meq./l, creatine kinase
(CK) of 223 U/l, CK-MB 16 U/l, and high-sensitive cardiac troponin
T of 0.78 ng/mL. The clinical diagnosis was NSTEMI. He was
treated with infusion of isosorbide dinitrate, heparin, oral aspirin
(100 mg/day), carvedilol (2.5 mg/day), rosuvastatin calcium
(2.5 mg/day), and enalapril (2.5 mg/day).
On day 4, plasma sodium concentration decreased to 123 meq./l
with low plasma osmolality of 237 mOs/l, high urinary osmolality
of 673 mOs/l, and high urinary sodium concentration of 250 meq./l.
At that point, we suspected drug-induced syndrome of inappropri-
ate antidiuretic hormone secretion (SIADH) and started the infusion
of normal saline for correction of hyponatremia. However, the chest
symptom exacerbated and ECG showed ST-segment elevation on
day 5 despite adequate infusion therapy. Percutaneous coronary
intervention (PCI) was urgently performed; coronary angiographyFig. 1. Electrocardiogram recorded on admission showed inverted T waves in V1–4.showed 90% narrowing of the left anterior descending artery,
segment 7 (Fig. 2). A drug-eluting stent was implanted successfully
during the same PCI. Infusion of normal saline was continued during
the PCI. However, marked disorientation and mental confusion
developed after the PCI. An urgent computed tomography showed
no brain lesion. Based on a further decrease in serum sodium
concentration to 113 meq./l, worsening hyponatremia was
suspected as the cause of the disorder of consciousness. We
started the correction of sodium concentration using 3% sodium
chloride and stopped the prescription of enalapril, which was
thought to be the causative drug. Besides, he also showed low
concentration of cortisol (6.1 mg/dL, at the day before PCI), we
infused 100 mg hydrocortisone for 3 days. Serum sodium
concentration rose to 118 meq./l the following day, together
with recovery of mental status. Based on the improvement, the
infusion was replaced with normal saline. Although serum
sodium concentration continued to rise to 132 meq./l, the patient
was placed on oral sodium chloride intake to maintain serum
sodium concentration (Fig. 3).
Fig. 2.
Coronary angiogram showed 90% stenosis of the left anterior descending artery, segment 7 (left). A drug-eluting stent was deployed in the culprit lesion with
excellent result (right).
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Fig. 3.
Clinical course showing changes in serum sodium concentrations and cortisol. Hyponatremia progressively worsened after admission to the hospital. The lowest
sodium concentration was recorded the day after percutaneous coronary intervention (PCI). Hyponatremia continued after cessation of enalapril. Oral sodium
chloride was prescribed to increase serum sodium concentration. Sodium chloride supplementation was not needed following the use of hydrocortisone, which
was prescribed following the diagnosis of hypopituitarism.
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without any complaint. However, low cortisol level persisted for a
long time after discharge. Based on this ﬁnding, the patient
underwent a battery of hormonal assays after suspicion of adrenal
dysfunction.
The response of adrenocorticotropic hormone (ACTH) to
corticotropin releasing hormone (CRH) administration was almostblunted. Rapid ACTH test ﬁrst showed reduced increase of cortisol
concentration, but the continuous ACTH test showed normal
cortisol response (Table 1). Based on these ﬁndings, the provisional
diagnosis was secondary adrenocortical insufﬁciency due to ACTH
deﬁciency. Thyrotropin-releasing hormone (TRH) test and leute-
nizing hormone releasing hormone (LH-RH) test showed normal
response (Table 1). Next we performed the growth hormone
Table 1 Results of various hormonal tests.
Control 30 min 60 min 90 min 120 min Result
CRH test
ACTH (pg/mL) 32.3 38.6 39.9 32.5 33.9 Reduced
Cortisol (mg/dL) 5.4 5.9 6.7 6 5.4 Reduced
TRH test
TSH (mIU/mL) 2.54 13.73 10.95 8.11 6.33 Normal
PRL (ng/mL) 7.5 12.5 9.5 8 7.6 Normal
LH-RH test
LH (mIU/mL) 3.4 17.8 17.4 14.8 13 Normal
FSH (mIU/mL) 3.7 6.6 7.1 7.2 7 Normal
Rapid ACTH test
Cortisol (mg/dL) 2.2 7.7 9.2 9.9 9.2 Reduced
Control Day 1 Day 2 Day 3 Result
Continuous ACTH test
Urinary free-cortisol (mg/day) 12.4 43.4 318 735 Normal
Control 15 min 30 min 60 min Result
GHRP2 test
HGH (ng/mL) <0.1 0.2 0.4 0.3 Reduced
ACTH, adrenocorticotropic hormone; CRH, corticotropin releasing hormone; FSH, follicular-stimulating hormone; GHRP2, growth hormone releasing peptide 2; HGH, human
growth hormone; PRL, prolactin; TRH, thyrotropin-releasing hormone; TSH, thyroid-stimulating hormone; LH-RH, leutenizing hormone releasing hormone.
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hormone concentration raises more than 16 ng/mL; however, his
peak concentration was only 0.4 ng/mL (Table 1). The level of
insulin-like growth factor (IGF-1) showed low concentration
compared with age-adjusted standard (IGF-1: 41 ng/mL). Based
on the results of the hormonal assays, the patient was diagnosed
with severe adult growth hormone deﬁciency (AGHD).
The assessment by brain magnetic resonance imaging (MRI)
was difﬁcult because of his severe claustrophobia at ﬁrst, but we
could undertake this using the open MRI scanner. There were no
deﬁnite ﬁndings of macroadenoma, hypophysitis, pituitary apo-
plexy, or inﬁltration disorder.
Hydrocortisone was introduced for ACTH deﬁciency and the
amount of oral sodium chloride was gradually decreased. Oral
sodium chloride was ﬁnally withdrawn without subsequent
hyponatremia. Furthermore, resumption of enalapril was not
associated with changes in serum sodium concentrations, which
invalidated our previous diagnosis of drug-induced SIADH.
Discussion
We describe a patient with NSTEMI and prolonged hypona-
tremia caused by adrenal insufﬁciency with subsequent hypopi-
tuitarism. Hyponatremia sometimes accompanies ACS and
correlates with poor clinical outcome. Previous reports warned
that certain drugs used for the treatment of ACS, such as
angiotensin-converting enzyme inhibitors, can cause SIADH. In
our patient, we ﬁrst suspected the involvement of enalapril in
drug-induced SIADH; however, cessation of enalapril did not result
in improvement of hyponatremia.
Adrenal insufﬁciency is another cause of hyponatremia, and
long-term hypocortisolemia is one of its important symptoms. In
our patient, the ability to release ACTH in response to CRH was
impaired. In addition, treatment of the patient with cortisol
relieved continuous oral sodium chloride supplement. These
ﬁndings indicate that secondary adrenal insufﬁciency was the
cause of hyponatremia.
In addition to adrenal insufﬁciency, our hormonal assays
showed severely impaired growth hormone release in response to
GHRP2. Thus, the AGHD was considered a comorbid disease
involving adrenal insufﬁciency and hypopituitarism. In hypopitu-
itarism, hormone deﬁciency often shows this order: growth
hormone, FSH/LH, TSH, and ACTH. However, in our patient, noabnormalities were evident in FSH/LH and TSH functions. The most
common cause of hypopituitarism in adults is hypothalamic-
pituitary tumors or treatment of them with pituitary surgery
and/or radiotherapy [5]. Our patient had not undergone any brain
surgery, and no adenoma was visible on the MRI. While MRI cannot
rule out only a small pituitary adenoma, a close long-term follow-
up of the patient, including hormonal assays, is necessary to rule
out pituitary adenoma.
Growth hormone deﬁciency (GHD) is a known risk factor for
atherosclerosis. The severity of GHD correlates with high levels of
serum total cholesterol, low-density lipoprotein-C (LDL), truncal
fat, and risk of hypertension [6–8]. Furthermore, two previous
studies demonstrated that premature mortality in hypopituitarism
is due to increased cardiovascular mortality, which correlates with
GHD [9,10]. In our patient, hyponatremia had not been noted in
annual health examinations before his admission. NSTEMI seems
to have triggered hypocortisolemia and adrenal insufﬁciency,
because ACS raises the amount of ACTH and cortisol demand [11].
It is also possible that GHD promoted the progression of
atherosclerosis and development of ACS.
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